n-(Prop-2-yn-1-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95+%, 5g

(4-Bromo-1-methyl-1H-pyrazol-3-yl)methanol, 95.0%, 1g

Boc-D-Cys(Trt)-OH, 95.0%, 10g

(1R,2R)-2-(methylamino)cyclohexan-1-ol, 98%, 250mg

3-Methoxy-3-methylbutyl acetate, min. 98%, for synthesis, 500 ml, glass packaging

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 97%, 250mg

2,6-DIMETHYLQUINAZOLIN-4(3H)-ONE, 95.0%, 25g

tert-Butyl 1-(2-bromobenzoyl)piperidin-4-ylcarbamate, 95.0%, 1g

1-Bromo-2,3,4-trimethoxybenzene, 95.0%, 1g

4-Bromo-2-chlorobenzyl bromide, 95.0%, 10g

(3S,4R)-4-(BOC-AMINO)-3-FLUOROPIPERIDINE, 95.0%, 1g

4-Acetyl-1-naphthoic acid, 97%, 1g

3-(4-Bromo-2-fluorobenzoyl)thiophene, 97.0%, 5g